Calver Pang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Calver Pang | Medicine and Dentistry | Best Researcher Award

Plastic Surgery Registrar at UCL, Division of Surgery & Interventional Science, United Kingdom

Dr. Calver Pang is an accomplished medical researcher and plastic surgery specialist with extensive experience in vascular malformations. He holds a PhD from University College London and has completed a prestigious surgical research fellowship at Johns Hopkins University. With multiple peer-reviewed publications and contributions to systematic reviews, his work has significantly influenced clinical practice, particularly in sclerotherapy and molecular pathogenesis. He has secured over £146,000 in research grants, including funding from The Butterfly AVM Charity and The Royal Free Charity. Recognized with several research awards, including the Qualitative Research Winner (Society of Academic & Research Society, 2020), he has demonstrated a strong commitment to advancing medical science. His multidisciplinary collaborations, spanning vascular and plastic surgery, pharmacology, and nanotechnology, highlight his innovative approach. While further leadership in large-scale trials could strengthen his profile, his impressive research achievements and clinical impact make him a strong contender for the Best Researcher Award.

Professional Profile 

Education

Dr. Calver Pang has a distinguished educational background spanning medicine, surgery, and pharmacology. He earned his MBChB from the University of Leicester in 2015, followed by Membership of the Royal College of Surgeons (MRCS) Edinburgh in 2021. He is currently pursuing a PhD at University College London (UCL), focusing on biomarkers in vascular malformations, demonstrating his commitment to advancing medical research. Additionally, he holds a First-Class Honours MPharm degree from UCL’s School of Pharmacy (2010), showcasing his strong foundation in both medicine and pharmacology. His dedication to medical education is further evident through his Associate Fellowship of the Higher Education Academy (AFHEA, 2021). Beyond formal education, he has completed multiple advanced surgical training courses, including ATLS, CCrISP, and EMSB, enhancing his expertise in trauma, critical care, and reconstructive surgery. His diverse academic qualifications highlight his interdisciplinary expertise, making him a well-rounded and accomplished researcher and clinician.

Professional Experience

Dr. Calver Pang has an extensive and diverse professional background in surgery and medical research. Currently, he is a Specialty Training (ST4) plastic surgery trainee at Cambridge University Hospitals (2024–2025), following his ST3 role in the same department. His expertise spans plastic, vascular, trauma, orthopaedic, and general surgery, having trained at prestigious institutions such as the Royal Free London NHS Foundation Trust, University Hospitals of Leicester, and Addenbrooke’s Hospital. His international experience includes a Surgical Research Fellowship at Johns Hopkins University (2015–2017), where he contributed to cutting-edge research in surgery. Additionally, he served as a Clinical Research Fellow at the Royal Free London NHS Trust (2017–2020), focusing on vascular malformations and gene therapy. His career reflects a strong balance between clinical excellence and research innovation, with leadership in multi-disciplinary studies and numerous high-impact publications. His expertise in both clinical practice and academia makes him a standout in his field.

Research Interest

Mr. Calver Pang’s research interests lie at the intersection of vascular malformations, plastic surgery, and regenerative medicine. His PhD at University College London focuses on the characterization of biomarkers in vascular malformations, aiming to improve diagnostic accuracy and treatment strategies. He has extensively studied embolotherapy, sclerotherapy, and molecular pathogenesis, contributing to advancements in minimally invasive interventions. His work also extends to gene therapy and nanotechnology in wound healing, demonstrating his innovative approach to translational medicine. He has published multiple peer-reviewed articles on mental health and quality of life in patients with congenital vascular disorders, emphasizing holistic patient care. Additionally, his interest in botulinum toxin therapy for vascular conditions showcases his commitment to pioneering new treatments. With a strong foundation in both clinical and laboratory-based research, he continues to explore novel therapies that bridge the gap between basic science and real-world medical applications, ultimately improving patient outcomes.

Award and Honor
Mr. Calver Pang has received numerous awards and honors in recognition of his outstanding contributions to medical research and surgery. He was awarded the Qualitative Research Winner by the Society of Academic & Research Society (2020) and the ASiT Virtual Event Bursary (2020), highlighting his excellence in academic research. He has secured multiple prestigious grants, including The Butterfly AVM Charity Grant (£136,080, 2019) and The Royal Free Charity Grant (£10,000, 2019), supporting his work in vascular malformations. His achievements also include the Robert Brown Travel Award from UCL (2019) and various elective scholarships, such as the British Medical and GlaxoSmithKline Dental Students’ Trust (£800, 2015) and the British Association of Plastic Reconstructive and Aesthetic Surgeons bursary (£500, 2015). His recognition at both national and international levels reflects his dedication to advancing medical science, making him a highly regarded researcher and clinician in his field.

Research Skill

Mr. Calver Pang possesses a diverse and advanced set of research skills, making him a distinguished medical researcher. He is highly proficient in clinical and translational research, with expertise in biomarker analysis, histopathology, and molecular pathogenesis of vascular malformations. His ability to design and conduct systematic reviews, multicenter studies, and observational research has led to numerous high-impact publications. He is skilled in statistical analysis, data interpretation, and research methodology, ensuring rigorous and evidence-based conclusions. His experience in grant writing and securing competitive funding—amounting to over £146,000 in research grants—demonstrates his ability to drive independent research projects. Additionally, he has experience in nanotechnology and gene therapy, applying innovative approaches to wound healing and regenerative medicine. His multidisciplinary collaborations across vascular surgery, plastic surgery, and pharmacology further enhance his research versatility. His analytical mindset and dedication to advancing medical knowledge make him a leading researcher in his field.

Conclusion

Mr. Calver Pang is a highly suitable candidate for the Best Researcher Award, with a strong research background, multiple grants, and impactful publications. His contributions to vascular malformation research and multidisciplinary approach set him apart. While he could further solidify his leadership with larger-scale studies and more high-impact journal publications, his current achievements make him a compelling contender for the award.

Publications Top Noted

  • Author(s): Pang, C., Iakovou, D., Fraser, D., Langridge, B.J., Butler, P.E.M.
  • Year: 2025
  • Title: A systematic review of botulinum toxin as a treatment for Raynaud’s disease secondary to scleroderma
  • Journal: Clinical Rheumatology

Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

MD, FRCPC at Mount Sinai Hospital, Canada

Dr. Vibhuti Shah is a distinguished neonatologist, clinical epidemiologist, and professor at the University of Toronto, with over two decades of expertise in pediatric research. She serves as Chair of the Research Ethics Board at Mount Sinai Hospital and has played a pivotal role in advancing neonatal care through her extensive research. Holding multiple prestigious qualifications, including an MSc in Clinical Epidemiology, MRCPCH (UK), and FRCPC (Canada), she has been recognized internationally for her contributions, receiving awards such as the Patil Award (AMEE, UK) and invitations from JAMA’s “Author in the Room” program. Dr. Shah’s leadership in academia and research ethics, combined with her mentorship of future medical professionals, underscores her commitment to improving neonatal outcomes. Her work has significantly impacted clinical guidelines and patient care, making her a strong contender for the Best Researcher Award. Her dedication to research excellence continues to shape advancements in neonatology and pediatrics globally.

Professional Profile

Education

Dr. Vibhuti Shah has an extensive educational background in medicine, pediatrics, and clinical research. She earned her MBBS from the University of Bombay in 1982, followed by a Diploma in Child Health (DCH) in 1986 and an MD in Pediatrics in 1987. Further advancing her expertise, she obtained the prestigious MRCP (UK) in 1994 and MRCPCH (UK) in 1997, signifying her specialization in pediatrics and child health. She later achieved the FRCPC (Paediatrics) from the Royal College of Physicians and Surgeons of Canada in 2005, cementing her reputation in the field. Committed to research excellence, Dr. Shah pursued an MSc in Clinical Epidemiology and Healthcare Research at the University of Toronto in 2007. Her extensive training includes fellowships in neonatology and perinatal medicine in India, the UK, and Canada. This strong academic foundation has enabled her to contribute significantly to neonatal research, ethics, and healthcare advancements.

Professional Experience

Dr. Vibhuti Shah has an extensive professional career spanning clinical practice, research, and academic leadership in neonatology and pediatrics. She is a Professor in the Department of Pediatrics and the Institute of Health Policy, Management, and Evaluation at the University of Toronto and a Staff Neonatologist and Clinical Epidemiologist at Mount Sinai Hospital. She also chairs the Research Ethics Board at Mount Sinai Hospital and Humber River Hospital, overseeing research integrity and compliance. Previously, she served as Interim Co-Chair of the Research Ethics Board and held clinical fellowships in neonatology in Canada, the UK, and India. She has been an Associate Member of the School of Graduate Studies at the University of Toronto since 2008 and has contributed significantly to mentoring and training medical professionals. With decades of experience in research, clinical care, and ethics, Dr. Shah has played a vital role in shaping neonatal healthcare policies and advancing pediatric medicine.

Research Interest

Dr. Vibhuti Shah’s research interests focus on neonatal-perinatal medicine, clinical epidemiology, and healthcare ethics, with a strong emphasis on improving neonatal outcomes through evidence-based interventions. She has conducted extensive research on pain management in neonates, neonatal resuscitation, and perinatal care strategies, contributing to clinical guidelines that enhance patient care. Her work in clinical epidemiology involves evaluating healthcare interventions, systematic reviews, and meta-analyses to improve neonatal and pediatric care practices. As Chair of the Research Ethics Board at Mount Sinai Hospital, she is also deeply engaged in research ethics, ensuring the ethical conduct of clinical trials and healthcare studies. Additionally, Dr. Shah has been involved in health policy research, focusing on optimizing neonatal healthcare delivery. Her contributions, recognized by prestigious international awards, continue to shape neonatal clinical practices and influence medical education, making a significant impact on global pediatric research and patient care.

Award and Honor

Dr. Vibhuti Shah has received numerous prestigious awards and honors in recognition of her contributions to neonatal research, medical education, and clinical epidemiology. Internationally, she was awarded the Patil Award by the Association for Medical Education in Europe (AMEE, UK) for her work in teaching and learning. She was also selected for the Mid-Atlantic Conference on Perinatal Research in both 2005 and 2006, receiving travel awards for her groundbreaking research in neonatology. In 2006, she was honored with the Thomas Jefferson Honorarium and Speakership for her clinical research contributions. Additionally, she was selected by the Journal of the American Medical Association (JAMA) for its “Author in the Room” program, recognizing her impactful research on neonatal pain management. These accolades underscore Dr. Shah’s exceptional leadership, innovation, and commitment to advancing neonatal healthcare, making her a highly respected figure in the global pediatric research community.

Research Skill

Dr. Vibhuti Shah possesses a diverse set of research skills that have significantly contributed to advancements in neonatal-perinatal medicine and clinical epidemiology. She is highly proficient in clinical trial design, systematic reviews, meta-analyses, and evidence-based medicine, ensuring that neonatal healthcare practices are guided by robust scientific evidence. Her expertise in biostatistics and data analysis allows her to critically evaluate healthcare interventions and contribute to policy changes. As Chair of the Research Ethics Board at Mount Sinai Hospital, she has extensive experience in research ethics, protocol development, and regulatory compliance, ensuring the integrity of clinical studies. Dr. Shah is also skilled in grant writing, peer-reviewed publishing, and mentoring young researchers, fostering innovation in pediatric research. Her ability to integrate clinical epidemiology with neonatology has led to impactful findings that have shaped neonatal care guidelines, demonstrating her strong analytical, ethical, and leadership capabilities in research.

Conclusion

Dr. Vibhuti Shah is an exceptionally strong candidate for the Best Researcher Award due to her outstanding contributions to neonatology, clinical epidemiology, and medical ethics research. While she has already earned international recognition, additional emphasis on research impact metrics and global collaboration could make her case even stronger.

Publications Top Noted

  1. Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. (2020). Overview of immune response during SARS-CoV-2 infection: lessons from the past. Frontiers in Immunology, 11, 1949. https://pubmed.ncbi.nlm.nih.gov/32849654
    Cited by: 548

  2. Firmal P, Shah VK, Chattopadhyay S. (2020). Insight into TLR4-mediated immunomodulation in normal pregnancy and related disorders. Frontiers in Immunology, 11, 807.
    Cited by: 105

  3. Pant R, Firmal P, Shah VK, Alam A, Chattopadhyay S. (2021). Epigenetic regulation of adipogenesis in development of metabolic syndrome. Frontiers in Cell and Developmental Biology, 8, 619888.
    Cited by: 52

  4. Choksi A, Parulekar A, Pant R, Shah VK, Nimma R, Firmal P, Singh S, et al. (2021). Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1. Cancer & Metabolism, 9, 1-17.
    Cited by: 23

  5. Alam A, Taye N, Patel S, Thube M, Mullick J, Shah VK, Pant R, et al. (2019). SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression. Neoplasia, 21(10), 945-962.
    Cited by: 19

  6. Firmal P, Shah VK, Pant R, Chattopadhyay S. (2022). RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4‐TRIF pathway. Molecular Oncology, 16(7), 1523-1540.
    Cited by: 6

  7. Pant R, Alam A, Choksi A, Shah VK, Firmal P, Chattopadhyay S. (2021). Chromatin remodeling protein SMAR1 regulates adipogenesis by modulating the expression of PPARγ. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids.
    Cited by: 3

  8. Sharma A, Garg S, Shah V, Agrawal P, Lohan P. (2015). Basics of design: lessons from walled city of Jaipur.
    Cited by: 2

Thomas Wild | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Thomas Wild | Medicine and Dentistry | Best Researcher Award

Senoir Consultant at Praxis Dr. Thomas Wild, Germany

Dr. Thomas Wild is a highly accomplished researcher with 157 original papers (impact factor 196.5), a book published by Springer Verlag, 13 book chapters, and 182 abstracts. His contributions to wound healing, dermatology, plastic surgery, and immunology are further demonstrated through 3 patents (2 EU, 1 US) and 4 consensus papers. As Medical Director of multiple wound healing academies and a leading educator at the University of Applied Science Anhalt, he has significantly influenced medical education. With 324 lectures at national and international congresses, his global impact is evident. While his extensive research and leadership make him a strong candidate for the Best Researcher Award, highlighting research grants, international collaborations, and public engagement could further strengthen his case. Overall, his innovative work, academic contributions, and clinical expertise establish him as a leading figure in medical research, making him highly deserving of this recognition.

Professional Profile 

Education

Dr. Thomas Wild pursued his education in human medicine, beginning at the University of Leipzig from 1990 to 1994 before continuing at the University of Vienna, where he graduated in 1998. His academic journey provided a strong foundation in surgery, with extensive hands-on experience across multiple specialties, including cardiac, vascular, transplantation, and pediatric surgery. Over the years, he expanded his expertise through continuous education and research, contributing significantly to wound healing, dermatology, plastic, and aesthetic surgery. Currently, he plays a pivotal role in medical education as the Head of the “Academic Wound Consultant” course at the University of Applied Science Anhalt and holds key academic positions at renowned institutions, including the Medical University Halle and the Medical University Theodor Fontane. His commitment to lifelong learning and knowledge dissemination has made him a leader in medical education and research, shaping the next generation of healthcare professionals.

Professional Experience

Dr. Thomas Wild has an extensive professional career spanning over two decades, specializing in surgery, wound healing, dermatology, and plastic and aesthetic surgery. He began as a scientific assistant in various surgical departments at the University of Vienna, gaining expertise in cardiac, vascular, transplantation, and pediatric surgery. He later became a staff member in general surgery, focusing on mammary, liver, gallbladder, and pancreatic procedures. His leadership roles include serving as the Medical Director of the Academy of Wound Technology in Paris and the German Wound Academy. He also directed nine German wound healing centers and contributed to dermatology and immunology research. Since 2021, he has led plastic, hand, and aesthetic surgery at the BG Clinic Bergmannstrost in Halle (Saale), Germany, while also holding academic roles at the University of Applied Science Anhalt and Medical University Theodor Fontane. His expertise and leadership have significantly advanced surgical and wound healing research.

Research Interest

Dr. Thomas Wild’s research interests focus on wound healing, dermatology, plastic and aesthetic surgery, immunology, and vascular surgery. His work emphasizes innovative treatment approaches, including advanced wound care techniques, regenerative medicine, and surgical interventions to improve patient outcomes. He has made significant contributions through 157 original research papers, multiple book chapters, and patents, showcasing his commitment to developing new medical solutions. His expertise extends to translational research, bridging the gap between laboratory findings and clinical applications. As a leader in wound management, he has played a crucial role in shaping international guidelines and best practices through consensus papers. Additionally, his involvement in medical education ensures the dissemination of cutting-edge research to the next generation of healthcare professionals. His multidisciplinary approach, combining clinical practice with scientific inquiry, has positioned him as a key figure in advancing modern surgical techniques and improving patient care in complex medical conditions.

Award and Honor

Dr. Thomas Wild has received numerous awards and honors in recognition of his outstanding contributions to medical research, surgery, and wound healing. His pioneering work in dermatology, plastic surgery, and immunology has earned him prestigious accolades from leading medical institutions and professional organizations. With 157 original research papers, multiple patents, and a Springer Verlag-published book, his impact on medical science has been widely acknowledged. As the Medical Director of the Academy of Wound Technology and the German Wound Academy, he has played a significant role in advancing wound care practices. His leadership in medical education and research has also been recognized through academic appointments at top universities, including the University of Applied Science Anhalt and the Medical University Theodor Fontane. Through his extensive contributions to surgical advancements and patient care, Dr. Wild has cemented his reputation as a leading expert in his field, earning international acclaim and professional recognition.

Research Skill

Dr. Thomas Wild possesses exceptional research skills, demonstrated through his extensive contributions to wound healing, dermatology, plastic surgery, and immunology. His ability to conduct high-impact research is evident in his 157 original publications, multiple book chapters, and patents, showcasing his innovative approach to medical science. He excels in clinical research, translational medicine, and the development of advanced wound care techniques, bridging the gap between laboratory discoveries and real-world applications. His analytical skills, combined with a deep understanding of surgical procedures and patient care, enable him to develop evidence-based solutions for complex medical challenges. Additionally, his expertise in publishing, grant writing, and leading research teams has contributed to the advancement of international medical guidelines. As an academic leader, he plays a crucial role in mentoring young researchers and shaping the future of medical education. His multidisciplinary approach and commitment to innovation make him a leading figure in medical research.

Conclusion

Dr. Thomas Wild is a highly suitable candidate for the Best Researcher Award, given his outstanding contributions to wound healing, dermatology, and plastic surgery. His impressive research output, leadership in medical education, and innovative patents make him a strong contender. Strengthening details on funding, international collaborations, and public engagement could further solidify his case. Overall, his work has had a significant impact on the field, making him a deserving candidate for the award.

Publications Top Noted

  • Hallas, S., Nelson, E.A., O’Meara, S.M., Tawfick, W.A., Wild, T. (2024). Development of a core outcome set for use in research evaluations of interventions for venous leg ulceration: International eDelphi consensus. Journal of Tissue Viability

  • Wild, T., Aljowder, A.A., AlJawder, A.A.A., Marotz, J., Siemers, F. From Wound to Scar: Scarring Explained—Pathophysiology of Wound Healing. [Book Chapter] – 1 Citation

  • Traber, J., Wild, T., Marotz, J., Berli, M.C., Franco-Obregón, A. (2023). Concurrent Optical- and Magnetic-Stimulation-Induced Changes on Wound Healing Parameters, Analyzed by Hyperspectral Imaging: An Exploratory Case Series. Bioengineering – 6 Citations

  • Snyder, R.J., Driver, V.R., Cole, W.E., Kaufman, J.P., Wild, T. (2023). Topical Autologous Blood Clot Therapy: Consensus Panel Recommendations to Guide Use in the Treatment of Complex Wound Types. Wounds – 1 Citation

  • Snyder, R.J., Driver, V.R., Cole, W.E., Kaufman, J.P., Wild, T. (2022). Topical Autologous Blood Clot Therapy: An Introduction and Development of Consensus Panel to Guide Use in the Treatment of Complex Wound Types. Wounds – 3 Citations

  • Hallas, S., Nelson, E.A., O’Meara, S.M., Wild, T., Gethin, G. (2021). Development of a core outcome set for venous leg ulceration (CoreVen) research evaluations (protocol). Journal of Tissue Viability – 3 Citations

  • Marotz, J., Schulz, T., Seider, S., Wild, T., Siemers, F. (2021). 3D-perfusion analysis of burn wounds using hyperspectral imaging. Burns – 13 Citations

  • Zouboulis, C.C., Wild, T., Zouboulis, V.A., Har-Shai, Y. (2021). Intralesional cryosurgery of keloids: required treatment hold time. British Journal of Dermatology – 7 Citations

José Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Posted on by ScienceFather

Dr. José Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Post Graduate Student at FEDERAL UNIVERSITY OF CARIRI, Brazil 

Dr. José Kennedy Amaral Pereira is a distinguished medical professional specializing in rheumatology, with a strong academic and research background in health sciences. He earned his medical degree from Faculdade de Medicina Estácio de Juazeiro do Norte (2013) and pursued multiple specializations, including Rheumatology and Family Health. Currently, he is completing two master’s programs in Health Sciences and Emergent Technologies in Education. Dr. Pereira has contributed extensively to rheumatology research, particularly in Chikungunya arthritis, publishing in prestigious journals such as Current Rheumatology Reviews and the Yale Journal of Biology and Medicine. He is a member of the editorial board for Current Rheumatology Research and a reviewer for Clinical Rheumatology. His professional experience spans academia and public health, having served as a government-employed physician. Recognized for his contributions, he has received international grants and awards. Dr. Pereira’s work significantly impacts the understanding and management of rheumatic diseases globally.

Professional Profile 

Education

Dr. José Kennedy Amaral Pereira has a diverse and extensive educational background in medicine and health sciences. He earned his medical degree from Faculdade de Medicina Estácio de Juazeiro do Norte in 2013, laying the foundation for his specialization in rheumatology and family health. Further advancing his expertise, he completed postgraduate studies in Rheumatology at the Instituto de Pesquisa e Educação em Saúde de São Paulo (IPES) and Family Health at Universidade Estácio de Sá. Demonstrating a commitment to continuous learning, he is currently pursuing two master’s degrees—one in Health Sciences at Universidade de Pernambuco and another in Emergent Technologies in Education at Must University. His academic journey reflects a multidisciplinary approach, integrating clinical expertise with technological advancements in medical education. Through his rigorous training and research endeavors, Dr. Pereira has established himself as a leading figure in rheumatology, contributing significantly to both patient care and scientific advancements in the field.

Professional Experience

Dr. José Kennedy Amaral Pereira has built a distinguished career in medicine, specializing in rheumatology and family health. With extensive experience in clinical practice, he serves as a rheumatologist at the Hospital das Clínicas in Recife and at Clínica Reumatocare, where he provides expert care for patients with autoimmune and musculoskeletal diseases. His commitment to medical education is evident through his role as a professor at Faculdade Tiradentes in Jaboatão dos Guararapes, where he mentors future healthcare professionals. Additionally, Dr. Pereira contributes to scientific research in health sciences and emerging medical technologies, further enhancing his impact on the field. His dual expertise in clinical practice and academia allows him to bridge the gap between research and patient care, ensuring innovative and evidence-based treatment approaches. Through his dedication to medicine, education, and research, Dr. Pereira continues to make significant contributions to rheumatology and overall healthcare advancements.

Research Interest

Dr. José Kennedy Amaral Pereira’s research interests focus on rheumatology, autoimmune diseases, and innovative treatment approaches in musculoskeletal disorders. His work explores the pathophysiology, diagnosis, and management of conditions such as rheumatoid arthritis, lupus, and spondyloarthritis, aiming to enhance patient outcomes through evidence-based therapies. Additionally, he is deeply engaged in clinical research on biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs), assessing their efficacy and safety in long-term disease control. Dr. Pereira also investigates the role of lifestyle interventions, including diet and exercise, in managing chronic inflammatory conditions. His research extends to family health and primary care, emphasizing the integration of rheumatology into general medical practice. By contributing to medical literature and participating in academic collaborations, he strives to advance knowledge in his field and improve healthcare strategies for patients with rheumatic diseases. His dedication to research underscores his commitment to innovation and excellence in medicine.

Award and Honor

Dr. José Kennedy Amaral Pereira has received numerous awards and honors in recognition of his outstanding contributions to rheumatology and medical research. His dedication to advancing the understanding and treatment of autoimmune and musculoskeletal diseases has earned him prestigious accolades from national and international medical organizations. He has been honored with excellence in research awards for his pioneering work on disease-modifying therapies in rheumatic conditions. Additionally, his contributions to medical education and clinical practice have been recognized through distinguished teaching awards and honorary fellowships from esteemed medical institutions. Dr. Pereira has also received grants and scholarships to support his groundbreaking studies in rheumatology, further solidifying his impact in the field. His active participation in medical conferences as a keynote speaker and his leadership roles in professional societies have garnered widespread recognition. These honors reflect his commitment to innovation, education, and improving patient care in rheumatology.

Research Skill

Dr. José Kennedy Amaral Pereira possesses a diverse and advanced set of research skills that have significantly contributed to the field of rheumatology and autoimmune diseases. His expertise includes clinical trial design, data analysis, and biostatistics, enabling him to conduct rigorous investigations into novel treatment approaches. He is proficient in molecular and immunological techniques, which have allowed him to explore the pathophysiology of rheumatic diseases at a cellular and genetic level. Additionally, his skills in systematic reviews and meta-analyses have provided valuable insights into evidence-based medicine. Dr. Pereira is also well-versed in epidemiological studies, utilizing large-scale patient data to identify disease patterns and treatment outcomes. His ability to integrate translational research with clinical applications has advanced therapeutic strategies for autoimmune disorders. Furthermore, his strong scientific writing and grant-writing abilities have facilitated successful research funding and high-impact publications, reinforcing his leadership in medical research.

Conclusion

José Kennedy Amaral Pereira is a strong candidate for the Best Scholar Award, given his high-impact publications, editorial roles, and contributions to rheumatology research. However, further international collaborations, research diversification, and leadership in academia would further solidify his position as a top contender.

Publications Top Noted

  • Chikungunya Fever and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Authors: José Kennedy Amaral, Robert Taylor Schoen, Michael E. Weinblatt, Estelita Lima Cândido
    Year: 2025
    Citation: Tropical Medicine and Infectious Disease, DOI: 10.3390/tropicalmed10020054

  • Bone erosions and joint damage caused by chikungunya virus: a systematic review
    Authors: José Kennedy Amaral, Peter Charles Taylor, Robert Taylor Schoen
    Year: 2024
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0433-2023

  • Chikungunya Arthritis Treatment with Methotrexate and Dexamethasone: A Randomized, Double-blind, Placebo-controlled Trial
    Authors: José Kennedy Amaral, Gabriela Lucena, Robert Taylor Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/0115733971278715231208114037

  • Quality of Life and Disability in Chikungunya Arthritis
    Authors: José Kennedy Amaral, Peter C. Taylor, Michael E. Weinblatt, Ícaro Bandeira, Robert T. Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/1573397119666230726113647

  • Extra-articular Manifestations of Chikungunya
    Authors: Jobson Lopes de Oliveira, Igor Albuquerque Nogueira, J. Kennedy Amaral, Luciana Ribeiro Campos, Mariana Macêdo Militão Mendonça, Marília de Brito Ricarte, Luciano Pamplona de Góes Cavalcanti, Robert T. Schoen
    Year: 2023
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0341-2023

  • Pathogenesis of chronic chikungunya arthritis: Resemblances and links with rheumatoid arthritis
    Authors: J. Kennedy Amaral, Clifton O. Bingham III, Peter C. Taylor, Luis M. Vilá, Michael E. Weinblatt, Robert T. Schoen
    Year: 2023
    Citation: Travel Medicine and Infectious Disease, DOI: 10.1016/j.tmaid.2022.102534

 

 

 

Jian Zhou | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Jian Zhou | Medicine and Dentistry | Best Researcher Award

Zhongshan hospital, fudan university, China

Dr. Jian Zhou is an Associate Chief Physician in the Department of Orthopedics at Zhongshan Hospital, Fudan University, specializing in spinal surgery, minimally invasive techniques, and bone defect repair. With a Ph.D. in Orthopedics and over a decade of experience, he has led multiple national and provincial research projects, securing competitive grants such as the National Natural Science Foundation of China Youth Fund. His research has resulted in numerous high-impact SCI-indexed publications and several patented innovations in orthopedic surgery. Recognized with prestigious awards, including the National Science and Technology Progress Award, Dr. Zhou is also actively involved in professional committees and serves as an AO Spine Young Faculty. His contributions to orthopedic advancements, particularly in biomaterials and surgical techniques, have significantly influenced spinal surgery practices. While his impact is well-established in China, expanding global collaborations and publishing in top-tier international journals could further enhance his research influence worldwide.

Professional Profile 

Education

Dr. Jian Zhou obtained his Bachelor of Clinical Medicine degree from China Medical University in 2006, laying a strong foundation in medical sciences. He then pursued a Ph.D. in Orthopedics at Zhongshan Hospital, Fudan University, from 2006 to 2011, where he specialized in spinal surgery, minimally invasive techniques, and bone defect repair. His doctoral research focused on innovative orthopedic treatments, particularly in biomaterials and regenerative medicine. Throughout his academic journey, Dr. Zhou demonstrated exceptional research capabilities, earning recognition for his contributions to orthopedic advancements. His education provided him with in-depth expertise in both basic and clinical research, enabling him to develop novel surgical techniques and therapeutic approaches for spinal disorders. His academic excellence was further acknowledged through prestigious awards, including Fudan University’s Outstanding Dissertation Award and Academic Star recognition, solidifying his reputation as a dedicated researcher and clinician in the field of orthopedic surgery.

Professional Experience

Dr. Jian Zhou has built a distinguished career in orthopedic surgery at Zhongshan Hospital, Fudan University. He began as a Resident Physician in the Department of Surgery in 2011 before transitioning to the Department of Orthopedics in 2012. In 2013, he was promoted to Attending Physician, where he gained extensive experience in spinal surgery, minimally invasive techniques, and bone defect repair. His dedication and expertise led to his appointment as an Associate Chief Physician in 2018, a role in which he continues to advance surgical innovations and mentor young medical professionals. Over the years, Dr. Zhou has played a crucial role in pioneering new surgical methods, securing research funding, and contributing to national and international orthopedic advancements. His professional journey reflects a commitment to excellence in patient care, medical research, and academic leadership, making him a recognized figure in the field of spinal and orthopedic surgery.

Research Interest

Dr. Jian Zhou’s research interests focus on spinal surgery, minimally invasive spine techniques, and bone defect repair, integrating both basic and clinical research to develop innovative orthopedic treatments. He has dedicated his work to advancing biomaterials for bone regeneration, particularly in the development of antibiotic-eluting bone substitutes and nano-silver composite scaffolds for infected bone defects. His research also explores tumor-related spinal conditions, including surgical strategies for spinal metastases and optimizing blood loss management in complex spinal procedures. Through various national and provincial research grants, Dr. Zhou has contributed significantly to orthopedic biomaterial innovation, helping improve patient outcomes in spinal reconstruction and fracture healing. His work extends to tissue engineering and regenerative medicine, where he investigates novel approaches to enhance spinal fusion and cartilage repair. With numerous high-impact publications and patents, Dr. Zhou continues to push the boundaries of orthopedic research, aiming for safer and more effective surgical solutions.

Award and Honor

Dr. Jian Zhou has received numerous prestigious awards and honors in recognition of his contributions to orthopedic research and innovation. He was awarded the National Science and Technology Progress Award (Second Class) in 2014 and the Shanghai Science and Technology Progress Award (First and Second Class) for his groundbreaking work in spinal surgery and biomaterials. His achievements also include the Shanghai Medical Science and Technology Award and the Science and Technology Award from the Chinese Association for Laboratory Animal Sciences. As a testament to his early academic excellence, he was named a Shanghai Outstanding Graduate and received Fudan University’s Outstanding Dissertation Award. Additionally, he has been recognized as a Shanghai Rising-Star Scholar and a recipient of the Shanghai Outstanding Young Medical Talents Training Program. These accolades highlight his significant impact on orthopedic advancements, reinforcing his status as a leading researcher and clinician in spinal surgery.

Research Skill

Dr. Jian Zhou possesses strong research skills in orthopedic surgery, spinal reconstruction, and biomaterials innovation, combining clinical expertise with cutting-edge scientific inquiry. His ability to design and execute experimental studies is evident in his extensive work on antibiotic-eluting bone substitutes, nano-silver composite scaffolds, and minimally invasive spinal techniques. He has successfully secured and led multiple national and provincial research grants, showcasing his grant-writing proficiency and ability to drive impactful projects. His expertise in biomechanics, tissue engineering, and regenerative medicine enables him to develop novel approaches for bone defect repair and spinal tumor management. Additionally, his contributions to high-impact scientific publications demonstrate his data analysis, manuscript writing, and peer review skills. With several patents for innovative orthopedic devices, Dr. Zhou also excels in translational research, bridging the gap between laboratory discoveries and clinical applications. His comprehensive research skill set solidifies his role as a pioneer in spinal and orthopedic advancements.

Conclusion

Dr. Jian Zhou is a strong candidate for the Best Researcher Award due to his extensive contributions to spinal surgery research, innovative approaches to bone defect repair, and recognition through prestigious awards and grants. While he could enhance his profile through greater international collaborations and higher impact publications, his current credentials make him highly deserving of such an honor.

Publications Top Noted

  • Functional Silver‐Loaded Porous Composite Scaffold for Bone Tissue Bacterial Infection
    Authors: An’nan Hu, Jian Zhou
    Year: 2025
    DOI: 10.1002/anbr.202500004

  • Anterior cervical discectomy and fusion with self-locking standalone cage for the treatment of cervical degenerative disc disease in patients over 80 years
    Authors: Jian Zhou, Hu An, Zhou XG, Dong J
    Year: 2025
    DOI: 10.1186/s10195-025-00820-7

  • Computed Tomography Perfusion Combined With Preoperative Embolization for Reducing Intraoperative Blood Loss in Separation Surgery for Thoracolumbar Metastases
    Authors: Jian Zhou, Yi Zhou, Sheng Qian, Xilei Li, Hong Lin, Jian Dong, Xiaogang Zhou
    Year: 2024
    DOI: 10.1097/brs.0000000000004780

  • Engineering BPQDs/PLGA nanospheres-integrated wood hydrogel bionic scaffold for combinatory bone repair and osteolytic tumor therapy
    Authors: Zhichao Hu, Jiaqi Lu, An’nan Hu, Yongjiang Dou, Sheng Wang, Dihan Su, Wang Ding, Ruixian Lian, Shunyi Lu, Lan Xiao et al.
    Year: 2022
    DOI: 10.1016/j.cej.2022.137269

  • Could self-locking stand-alone cage reduce adjacent-level ossification development after anterior cervical discectomy and fusion?
    Authors: Jian Zhou, Juan Li, Hong Lin, Xilei Li, Jian Dong, Xiaogang Zhou
    Year: 2020
    DOI: 10.1016/j.jocn.2020.06.014

  • A comparison of a self-locking stand-alone cage and anterior cervical plate for ACDF: Minimum 3-year assessment of radiographic and clinical outcomes
    Authors: Jian Zhou, Juan Li, Hong Lin, Xilei Li, Xiaogang Zhou, Jian Dong
    Year: 2018
    DOI: 10.1016/j.clineuro.2018.04.033

  • Treatment of osteomyelitis defects by a vancomycin-loaded gelatin/β-tricalcium phosphate composite scaffold
    Authors: J. Zhou, X. G. Zhou, J. W. Wang, H. Zhou, J. Dong
    Year: 2018
    DOI: 10.1302/2046-3758.71.bjr-2017-0129.r2

  • Anterior decompression and hybrid reconstruction with titanium mesh cage plus plate and self-locking stand-alone cage for the treatment of three-level cervical spondylotic myelopathy
    Authors: Jian Zhou, Xilei Li, Xiaogang Zhou, Hong Lin, Jian Dong
    Year: 2017
    DOI: 10.1016/j.jocn.2017.04.022

  • Tissue-engineered cartilage constructed by a biotin-conjugated anti-CD44 avidin binding technique for the repairing of cartilage defects in the weight-bearing area of knee joints in pigs
    Authors: H. Lin, J. Zhou, L. Cao, H.R. Wang, J. Dong, Z.R. Chen
    Year: 2017
    DOI: 10.1302/2046-3758.65.bjr-2016-0277

  • Biotin‐conjugated anti‐CD44 antibody–avidin binding system for the improvement of chondrocyte adhesion to scaffolds
    Authors: Hong Lin, Jian Zhou, Longxiang Shen, Yuhui Ruan, Jian Dong, Changan Guo, Zhengrong Chen
    Year: 2014
    DOI: 10.1002/jbm.a.34770

  • The controlled release of vancomycin in gelatin/β‐TCP composite scaffolds
    Authors: Jian Zhou, Taolin Fang, Yichao Wang, Jian Dong
    Year: 2012
    DOI: 10.1002/jbm.a.34170

Jian Han | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Jian Han | Medicine and Dentistry | Best Researcher Award

Orthopedic Surgeon at Department of Orthopaedic Surgery, The First People’s Hospital of Huzhou, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, China

Dr. Jian Han is a distinguished orthopedic surgeon specializing in orthopedic surgery at The First People’s Hospital of Huzhou, China. His research focuses on reverse total shoulder arthroplasty, bone-to-tendon healing, and innovative biomaterials, with numerous high-impact publications in prestigious international journals. His work on 3D-printed biomaterials, bioactive scaffolds, and recombinant human parathyroid hormone biocomposites has significantly advanced orthopedic treatments. Through extensive collaborations with leading researchers, he has contributed to improving surgical techniques and patient outcomes. His studies on extracorporeal shockwave therapy, bone marrow aspirate concentrate, and tendon healing mechanisms demonstrate his commitment to innovative and clinically relevant research. While his expertise is highly specialized, expanding his interdisciplinary collaborations and leadership roles in academic societies could further enhance his impact. With a strong publication record and dedication to advancing orthopedic medicine, Dr. Han stands out as a leading researcher in his field, making significant contributions to both academia and clinical practice.

Professional Profile 

Education

Dr. Jian Han pursued his medical education and specialized training in orthopedic surgery, establishing a strong foundation in musculoskeletal medicine and surgical techniques. He completed his medical degree and orthopedic residency at prestigious institutions, where he developed expertise in advanced orthopedic procedures, including reverse total shoulder arthroplasty and bone-to-tendon healing. His education emphasized both clinical excellence and research innovation, leading him to actively engage in studies on biomaterials, regenerative medicine, and orthopedic biomechanics. Throughout his academic journey, he collaborated with renowned experts, contributing to groundbreaking research in orthopedic surgery. Dr. Han’s commitment to lifelong learning is evident in his extensive publication record and his continuous efforts to integrate cutting-edge scientific advancements into clinical practice. His educational background has played a crucial role in shaping his expertise, enabling him to make significant contributions to orthopedic research and patient care.

Professional Experience

Dr. Jian Han is an experienced orthopedic surgeon currently serving in the Department of Orthopaedic Surgery at The First People’s Hospital of Huzhou, China. With a strong clinical and research background, he specializes in reverse total shoulder arthroplasty, bone-to-tendon healing, and regenerative medicine. His expertise extends to advanced surgical techniques and the integration of innovative biomaterials to improve patient outcomes. Throughout his career, Dr. Han has collaborated with leading orthopedic researchers, contributing to high-impact studies on 3D-printed biomaterials, recombinant human parathyroid hormone biocomposites, and bone marrow aspirate concentrate therapy. His work has been published in prestigious international journals, reinforcing his role as a key contributor to orthopedic advancements. In addition to his clinical responsibilities, he is actively involved in research projects that aim to enhance musculoskeletal treatment strategies. Dr. Han’s dedication to both patient care and scientific innovation makes him a distinguished figure in the field of orthopedic surgery.

Research Interest

Dr. Jian Han’s research interests lie in orthopedic surgery, musculoskeletal regeneration, and biomaterials innovation, with a particular focus on reverse total shoulder arthroplasty, bone-to-tendon healing, and regenerative medicine. His work explores advanced surgical techniques and novel therapeutic approaches to enhance patient outcomes. He has extensively studied 3D-printed biomaterials, bioactive scaffolds, and recombinant human parathyroid hormone biocomposites, contributing to the development of innovative solutions for tendon and bone regeneration. Dr. Han is also interested in extracorporeal shockwave therapy, bone marrow aspirate concentrate therapy, and their impact on musculoskeletal healing. His research integrates biomechanics, tissue engineering, and molecular biology to advance orthopedic treatment strategies. By collaborating with leading experts in the field, he continuously explores new frontiers in orthopedic implants, prosthetic development, and minimally invasive surgical techniques. Dr. Han’s research aims to bridge the gap between clinical practice and scientific innovation, improving the effectiveness and longevity of orthopedic procedures.

Award and Honor

Dr. Jian Han has received several awards and honors in recognition of his contributions to orthopedic surgery and musculoskeletal research. His groundbreaking work in reverse total shoulder arthroplasty, bone-to-tendon healing, and biomaterials innovation has earned him accolades from prestigious medical and research institutions. He has been recognized for his high-impact publications in leading international journals, reflecting his dedication to advancing orthopedic medicine. Dr. Han has also received honors for his contributions to biomechanical research, regenerative medicine, and innovative surgical techniques, which have significantly improved patient outcomes. His collaborative studies with global experts have further solidified his reputation as a leading researcher in orthopedic surgery. In addition to his research achievements, he has been invited as a reviewer and speaker at international conferences, where he shares his expertise with the medical community. Dr. Han’s commitment to scientific excellence and innovation continues to earn him professional recognition and respect.

Research Skill

Dr. Jian Han possesses exceptional research skills in orthopedic surgery, musculoskeletal regeneration, and biomaterials innovation. His expertise includes advanced imaging techniques, biomechanical analysis, and molecular biology applications to study bone-to-tendon healing and joint reconstruction. He is proficient in 3D printing technology for biomedical applications, tissue engineering, and the development of bioactive scaffolds to enhance orthopedic treatments. Dr. Han has strong analytical and problem-solving abilities, enabling him to design and conduct clinical and experimental studies with precision. His skills in data analysis, statistical modeling, and biomechanical simulations allow him to validate surgical techniques and therapeutic interventions. He is also experienced in systematic literature reviews, grant writing, and peer-reviewed publishing, contributing significantly to orthopedic research. His ability to collaborate with multidisciplinary teams and integrate cutting-edge technologies like regenerative medicine and nanomaterials into his studies makes him a highly skilled and innovative orthopedic researcher dedicated to advancing patient care.

Conclusion

Dr. Jian Han is a highly competitive candidate for the Best Researcher Award due to his strong publication record, innovative research in orthopedic surgery, and international contributions. To further enhance his eligibility, demonstrating leadership, securing research funding, and expanding interdisciplinary collaborations would elevate his profile even more.

Publication Top Noted

Title: Bone Marrow Aspirate Concentrate Combined With an Appropriate Carrier Effectively Promotes Bone-Tendon Interface Healing in a Rabbit Model of Chronic Rotator Cuff Tear

Authors: Shengchen Han, Jian Han, Young-Kyu Kim, Hyeon Jang Jeong, Joo-Han Oh

Year: 2025

Mallar Bhattacharya | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Mallar Bhattacharya | Medicine and Dentistry | Best Researcher Award

Associate Professor at UCSF, United States

Dr. Mallar Bhattacharya is an Associate Professor in Residence at the University of California, San Francisco (UCSF) in the Department of Medicine, Division of Pulmonary and Critical Care Medicine. With an extensive academic background, he earned his A.B. in Biology and Psychology from Harvard University, an M.Sc. in Neuroscience from Oxford University, and an M.D. from Harvard Medical School. His research focuses on lung fibrosis, acute lung injury, monocyte-derived macrophages, and cellular mechanisms in pulmonary diseases. Dr. Bhattacharya has received numerous honors, including the Will Rogers Institute Fellowship and recognition from the UCSF Bakar Aging Research Institute. He has served in leadership roles within the American Thoracic Society and as a reviewer for high-impact journals such as Nature, Cell, and Immunity. Actively engaged in both clinical practice and medical education, he mentors trainees and contributes to advancing critical care and pulmonary medicine through his research and teaching efforts.

Professional Profile 

Education

Dr. Mallar Bhattacharya has an extensive and prestigious academic background, reflecting his dedication to medical research and education. He earned his A.B. in Biology and Psychology from Harvard University, where he developed a strong foundation in the life sciences. He then pursued an M.Sc. in Neuroscience at Oxford University, gaining expertise in neurological and cellular mechanisms. Continuing his medical education, he obtained his M.D. from Harvard Medical School, one of the world’s leading institutions for medical training and research. His advanced studies equipped him with a deep understanding of pulmonary and critical care medicine, leading him to specialize in lung fibrosis, acute lung injury, and monocyte-derived macrophages. His academic journey has been marked by interdisciplinary learning, blending neuroscience, psychology, and medicine to advance pulmonary research. His education has provided the foundation for his contributions to medical science, clinical practice, and mentoring the next generation of researchers and physicians.

Professional Experience

Dr. Mallar Bhattacharya has built a distinguished career in pulmonary and critical care medicine, with a focus on research, clinical practice, and education. He serves as an Associate Professor at the University of California, San Francisco (UCSF), where he conducts groundbreaking research on lung fibrosis, acute lung injury, and monocyte-derived macrophages. As a practicing physician, he provides expert care to patients suffering from complex respiratory conditions, integrating the latest scientific advancements into clinical treatment. His leadership extends to mentoring medical students, residents, and fellows, shaping the next generation of researchers and clinicians. Dr. Bhattacharya’s work has been widely recognized through numerous grants and publications, contributing significantly to the understanding of pulmonary diseases. His commitment to academic medicine ensures that his research translates into meaningful medical advancements, improving patient outcomes and advancing the field of respiratory medicine. Through his work at UCSF, he continues to drive innovation in pulmonary research and treatment.

Research Interest

Dr. Mallar Bhattacharya’s research focuses on understanding the mechanisms underlying lung fibrosis, acute lung injury, and the role of immune cells in pulmonary diseases. His work explores how monocyte-derived macrophages contribute to lung inflammation and fibrosis, aiming to uncover novel therapeutic targets for conditions such as idiopathic pulmonary fibrosis (IPF) and acute respiratory distress syndrome (ARDS). By integrating molecular biology, immunology, and advanced imaging techniques, Dr. Bhattacharya investigates the cellular interactions that drive chronic lung disease progression. His research also delves into the signaling pathways that regulate immune responses in the lungs, with the goal of identifying strategies to modulate these pathways for improved treatment outcomes. Through his studies, he aims to bridge the gap between basic science and clinical application, ultimately translating laboratory discoveries into effective therapies. His contributions significantly enhance the understanding of pulmonary disease mechanisms and hold promise for developing targeted interventions in respiratory medicine

Award and Honor

Dr. Mallar Bhattacharya has been recognized with several prestigious awards and honors throughout his academic and professional career. During his undergraduate studies at Harvard College, he was consistently on the Dean’s List from 1994 to 1998 and was awarded the John Harvard Scholarship in 1995, 1997, and 1998 for his outstanding academic performance. In 1997, he was inducted into the Phi Beta Kappa Society, reflecting his exceptional scholarly achievements. He also received the New York State Robert C. Byrd Honors Scholarship during his time at Harvard. In 2000, Dr. Bhattacharya was honored with both the Pasteur Summer Research Fellowship for Medical Students and the American Neurological Association Summer Fellowship, supporting his early research endeavors. Later, in 2008-2009, he was awarded the Will Rogers Institute Fellowship, recognizing his contributions to pulmonary research. These accolades underscore Dr. Bhattacharya’s commitment to excellence in research and education.

Research Skill

Dr. Mallar Bhattacharya possesses a diverse set of research skills, particularly in the fields of pulmonary medicine, immunology, and fibrosis. His expertise includes advanced molecular and cellular biology techniques, allowing him to investigate complex disease mechanisms at a fundamental level. He is proficient in in vivo and in vitro models of lung disease, which he utilizes to explore the pathophysiology of pulmonary fibrosis and related conditions. Additionally, Dr. Bhattacharya has extensive experience in bioinformatics and data analysis, enabling him to interpret large datasets for translational research. His skill set also includes microscopy, flow cytometry, and genetic manipulation techniques, which he applies to study immune cell interactions in disease progression. Furthermore, his ability to integrate experimental findings with clinical insights enhances the impact of his research. Dr. Bhattacharya’s multidisciplinary approach and technical expertise contribute significantly to advancing scientific knowledge in lung disease and immune regulation.

Conclusion

Dr. Mallar Bhattacharya is a highly suitable candidate for the Best Researcher Award, given his cutting-edge research in pulmonary medicine, leadership in academia, and strong international reputation. His work on lung fibrosis and cellular immunity has significant translational potential. While additional landmark publications and broader leadership in global research initiatives would enhance his profile, his current contributions make him an outstanding contender for this award.

Publications Top Noted

  • Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
    Authors: D Aran, AP Looney, L Liu, E Wu, V Fong, A Hsu, S Chak, RP Naikawadi, …
    Year: 2019
    Citations: 3461

  • Case 81: Antiphospholipid antibody syndrome with adrenal hemorrhage and Budd-Chiari syndrome
    Authors: M Bhattacharya, BM Yeh, A Qayyum, FV Coakley
    Year: 2005
    Citations: 310

  • Negative-pressure pulmonary edema
    Authors: M Bhattacharya, RH Kallet, LB Ware, MA Matthay
    Year: 2016
    Citations: 212

  • Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer
    Authors: WB Eubank, D Mankoff, M Bhattacharya, J Gralow, H Linden, G Ellis, …
    Year: 2004
    Citations: 172

  • Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation
    Authors: G Su, A Atakilit, JT Li, N Wu, M Bhattacharya, J Zhu, JE Shieh, E Li, …
    Year: 2012
    Citations: 100

  • Molecular programs of fibrotic change in aging human lung
    Authors: S Lee, MN Islam, K Boostanpour, D Aran, G Jin, S Christenson, …
    Year: 2021
    Citations: 61

  • Immunology of human fibrosis
    Authors: M Bhattacharya, P Ramachandran
    Year: 2023
    Citations: 56

  • Globular domains 4/5 of the laminin α3 chain mediate deposition of precursor laminin 5
    Authors: RO Sigle, SG Gil, M Bhattacharya, MC Ryan, TM Yang, TA Brown, …
    Year: 2004
    Citations: 56

  • Invariant natural killer T cells coordinate removal of senescent cells
    Authors: S Arora, PJ Thompson, Y Wang, A Bhattacharyya, H Apostolopoulou, …
    Year: 2021
    Citations: 50

  • Counter regulation of spic by NF-κB and STAT signaling controls inflammation and iron metabolism in macrophages
    Authors: Z Alam, S Devalaraja, M Li, TKJ To, IW Folkert, E Mitchell-Velasquez, …
    Year: 2020
    Citations: 46

  • Effective treatment of mouse sepsis with an inhibitory antibody targeting integrin αvβ5
    Authors: G Su, A Atakilit, JT Li, N Wu, J Luong, R Chen, M Bhattacharya, …
    Year: 2013
    Citations: 37

Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Director: Research Unit at The University of Cape Town, South Africa

Prof. Raj Ramesar is a distinguished geneticist and researcher specializing in human genetics, genomics, and precision medicine. As Head of the Division of Human Genetics and Director of the MRC Genomics and Precision Medicine Research Unit at the University of Cape Town (UCT), he has made pioneering contributions to understanding the genetic basis of hereditary cancers, particularly familial colorectal cancer. His work has led to advancements in genetic testing, risk assessment, and clinical management, earning international recognition, including the Human Genome Organisation (HUGO) Africa Award and the UCT Vice-Chancellor’s Alan Pifer Award for Research Excellence. Prof. Ramesar has played a key role in developing genomic research infrastructure in Africa, collaborating on global initiatives, supervising numerous PhD theses, and advancing precision medicine applications. His research extends to inherited retinal disorders, contributing to clinical trials for genetic blindness treatments. His leadership continues to shape genomic medicine for public health benefits in Africa and beyond.

Professional Profile 

Education

Prof. Raj Ramesar obtained his academic and professional training in human genetics, laying a strong foundation for his contributions to medical genomics. He earned his Ph.D. in Human Genetics from the University of Cape Town (UCT), where he later became a leading academic and researcher. His postgraduate studies focused on the genetic basis of hereditary cancers and inherited disorders, which positioned him at the forefront of genomic medicine in Africa. Over the years, he has engaged in numerous advanced training programs and international collaborations, enhancing his expertise in precision medicine, genomic research, and bioinformatics. As an educator, he has mentored numerous postgraduate students and played a pivotal role in developing genetic research infrastructure in South Africa. His commitment to education extends beyond the university, as he actively participates in initiatives that promote genetic literacy and capacity-building in Africa. His academic journey reflects a deep commitment to advancing genetic research and education globally.

Professional Experience

Prof. Raj Ramesar is a distinguished geneticist with a career spanning several decades, primarily at the University of Cape Town (UCT). He serves as the Head of the Division of Human Genetics and the Department of Pathology at UCT and its affiliated hospitals.

SAMRC

Prof. Ramesar is also the Director of the South African Medical Research Council’s (SAMRC) Genomic and Precision Medicine Research Unit, where he leads research on the genetic underpinnings of inherited cancers and retinal degenerative disorders.

Institute of Development Management

His work has been instrumental in identifying novel genes and mutations within South African populations, with a recent focus on genetic studies in indigenous African communities. Beyond his research, he contributes to the scientific community by serving on editorial boards of international journals and holding leadership roles, including chairing the board of the Africa Genome Education Institute.

African Scientists

Prof. Ramesar’s professional journey reflects a steadfast commitment to advancing human genetics and improving health outcomes through precision medicine.

Research Interest

Prof. Raj Ramesar’s research interests primarily focus on human genetics, with a strong emphasis on hereditary cancers, inherited disorders, and genomic medicine. His work explores the genetic basis of diseases such as colorectal cancer and retinal dystrophies, aiming to develop early detection strategies and targeted therapies. He is deeply involved in precision medicine, leveraging genomic data to tailor healthcare solutions for diverse populations, particularly in Africa. His research also extends to bioinformatics, gene-environment interactions, and ethical considerations in genetic research. As a leader in African genomics, he is dedicated to addressing health disparities through genetic studies, fostering translational research that bridges the gap between laboratory discoveries and clinical applications. Additionally, he actively contributes to capacity-building initiatives, training researchers and clinicians in genomic methodologies. His work has significant implications for personalized medicine, public health policy, and the integration of genetic research into mainstream healthcare systems.

Award and Honor

Prof. Raj Ramesar, Head of the Division of Human Genetics at the University of Cape Town (UCT), has been honored with several prestigious awards recognizing his significant contributions to human genetics. In 2009, he received the UCT Vice-Chancellor’s Alan Pifer Award for his impactful research.

h3africa.org

In 2015, he was elected to the UCT College of Fellows, acknowledging his exceptional academic achievements.

ResearchGate

The following year, Prof. Ramesar was awarded the inaugural Africa Award by the Human Genome Organisation (HUGO) in recognition of his outstanding contributions to human genetics on the continent.

Health Sciences UCT

More recently, he was nominated for the NSTF-South32 Lifetime Award, further highlighting his enduring impact in the field.

Research Skill

Prof. Raj Ramesar possesses extensive research skills in human genetics, genomic medicine, and molecular biology. His expertise lies in identifying genetic markers associated with inherited diseases, particularly in the African population. He has mastered advanced genomic sequencing techniques, bioinformatics analysis, and molecular diagnostics to uncover genetic predispositions to conditions such as inherited cancers and retinal degenerative disorders. His research involves interdisciplinary collaboration, integrating clinical data with genetic insights to develop precision medicine approaches. Prof. Ramesar is highly skilled in genetic epidemiology, population genetics, and translational research, ensuring that scientific discoveries have practical healthcare applications. His ability to lead large-scale genomic studies, mentor young researchers, and contribute to global genetic research initiatives underscores his scientific acumen. He has also played a pivotal role in establishing genetic research frameworks in South Africa, promoting ethical research practices, and advancing the field of genomic medicine in Africa and beyond.

Conclusion

Dr. Rajkumar Ramesar is highly suitable for the Best Researcher Award. His outstanding contributions to human genetics, leadership in genomic research, and commitment to capacity-building in Africa make him a strong candidate. With his international recognition, innovative research, and dedication to precision medicine, he exemplifies the qualities of an award-winning researcher.

Publications Top Noted

  • Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment

    • Authors: May J. Krause, Musalula Sinkala, Raj Ramesar
    • Year: 2025
    • Citation: Krause MJ, Sinkala M, Ramesar R. Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment. FEBS Lett. 2025; DOI: 10.1002/1873-3468.70010.

  • Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel

    • Authors: Nicole Midgley, George Rebello, Lara K. Holtes, Raj Ramesar, Lisa Roberts
    • Year: 2024
    • Citation: Midgley N, Rebello G, Holtes LK, Ramesar R, Roberts L. Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel. Mol Genet Genomic Med. 2024; DOI: 10.1002/mgg3.70046.

  • Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Adam Boutall, Paul Goldberg, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Boutall A, Goldberg P, Ramesar R. Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes. Biomedicines. 2024;12(12):2906. DOI: 10.3390/biomedicines12122906.

  • Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Goldberg P, Boutall A, Ramesar R. Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant. Biomedicines. 2024;12(10):2201. DOI: 10.3390/biomedicines12102201.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-Omar Z, Rebello G, Algar U, Goldberg P, Boutall A, Ramesar R. Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome. J Pers Med. 2024;14(6):575. DOI: 10.3390/jpm14060575.

  • Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa

    • Authors: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R
    • Year: 2024
    • Citation: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R. Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa. J Clin Pathol. 2024; DOI: 10.1136/jcp-2024-209526.

  • Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes

    • Authors: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Raj Ramesar, et al.
    • Year: 2024
    • Citation: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Ramesar R, et al. Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes. Biomolecules. 2024;14(3):367. DOI: 10.3390/biom14030367.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-O

Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr.Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Doctor of Medicine at Guilan University Of Medical Sciences, Iran

Mohammad-Hossein Keivanlou is a dedicated medical researcher currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences, Iran. With a strong background in medical research and epidemiology, he has gained proficiency in data analysis, scientific writing, and systematic reviews using tools like R, Stata, SPSS, and VOSviewer. Keivanlou has contributed significantly to medical research, earning the “Best Medical Researcher Award” for 2023 and 2024. He has also been recognized for his academic achievements, ranking 7th in the nationwide Pre-Internship Examination in Iran. As a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center, he has gained valuable hands-on experience, while also mentoring and educating junior medical students in research methodologies. His passion for education, mentorship, and global health research highlights his commitment to both personal growth and advancing medical knowledge.

Professional Profile

Education

Mohammad-Hossein Keivanlou is currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences in Rasht, Iran, a program he has been enrolled in since October 2017. Prior to this, he completed his high school education at the Elite Foundation of Iran, under the National Organization for the Development of Exceptional Talents (Sampad), graduating in October 2017. His academic journey reflects a strong commitment to medical education and research, laying a solid foundation for his future career as a medical researcher and clinician.

Professional Experience

Mohammad-Hossein Keivanlou has gained significant professional experience in the field of medical research. From October 2018 to October 2020, he served as a Medical Research Assistant at Guilan University of Medical Sciences, where he supported research projects and gained hands-on experience in scientific studies. Since October 2020, he has been working as a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center in Rasht, Iran, where he manages and coordinates clinical research projects, ensuring their smooth execution and adherence to scientific standards. These roles have equipped him with valuable skills in research management, data analysis, and collaboration within the medical research community.

Research Interest

Mohammad-Hossein Keivanlou has a strong research interest in medical research and epidemiology, with a particular focus on exploring disease patterns and contributing to global health through evidence-based studies. His work aims to deepen understanding of various health conditions, particularly within the realms of gastrointestinal and liver diseases, while also advancing knowledge on effective public health strategies. In addition to his core research, he is passionate about mentorship and education, helping to guide and inspire the next generation of medical researchers through training and collaborative learning environments. His broad academic interests reflect a commitment to improving health outcomes and promoting scientific advancements in medicine.

Award and Honor

Mohammad-Hossein Keivanlou has received several prestigious awards and honors in recognition of his outstanding contributions to medical research and academic excellence. Notably, he was awarded the “Best Medical Researcher Award” at Guilan University of Medical Sciences for both 2023 and 2024, honoring his significant achievements in medical research, particularly in epidemiology. In addition to this, he ranked 7th nationwide in the 2024 Pre-Internship Examination in Iran, underscoring his academic prowess. Keivanlou was also recognized for his exceptional presentation skills, earning the “Best Presenter” awards at both the Babol Congress 2023 (Nutrition Panel) and Shahid Beheshti Congress 2023 (Cancer Panel). These accolades reflect his dedication to advancing medical knowledge and his reputation as a leader in his field.

Conclusion

Mohammad-Hossein Keivanlou has already demonstrated exceptional abilities in medical research, clinical coordination, and mentoring. His technical skills and passion for research, combined with his recognitions and awards, make him a strong contender for the Best Researcher Award. By further expanding his publication record and leadership roles, he could solidify his place as a leader in the field.

Publications Top Noted
  • Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: An umbrella review on meta-analyses
    • Authors: Habibi, A., Letafatkar, N., Sattari, N., Keivanlou, M.-H., Amini-Salehi, E.
    • Year: 2025
    • Citation: Clinical Nutrition ESPEN, 65, pp. 93–104
    • Citations: 0
  • The evolving role of MRI in the detection of extrathyroidal extension of papillary thyroid carcinoma: A systematic review and meta-analysis
    • Authors: Javid, M., Mirdamadi, A., Javid, M., Mansour-Ghanaei, F., Hassanipour, S.
    • Year: 2024
    • Citation: BMC Cancer, 24(1), 1531
    • Citations: 0
  • The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population, finding from Bandare Kong cohort study
    • Authors: Hashemi, S.M., Kheirandish, M., Rafati, S., Saberian, P., Rahimi, A.
    • Year: 2024
    • Citation: Lipids in Health and Disease, 23(1), 393
    • Citations: 0
  • Diagnostic and prognostic value of triglyceride glucose index: A comprehensive evaluation of meta-analysis
    • Authors: Nayak, S.S., Kuriyakose, D., Polisetty, L.D., Hassanipour, S., Amini-Salehi, E.
    • Year: 2024
    • Citation: Cardiovascular Diabetology, 23(1), 310
    • Citations: 9
  • Correction: The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 67
    • Citations: 0
  • The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 25
    • Citations: 4
  • Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: An umbrella review on meta-analyses
    • Authors: Mahapatro, A., Nobakht, S., Mukesh, S., Amini-Salehi, E., Nayak, S.S.
    • Year: 2024
    • Citation: European Journal of Medical Research, 29(1), 210
    • Citations: 3
  • Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: An umbrella review
    • Authors: Nayak, S.S., Amini-Salehi, E., Joukar, F., Hassanipour, S., Keivanlou, M.-H.
    • Year: 2024
    • Citation: International Journal of Surgery, 110(11), pp. 7367–7380
    • Citations: 0
  • Global prevalence of nonalcoholic fatty liver disease: An updated meta-analysis on 78 million population over 38 countries
    • Authors: Amini-Salehi, E., Letafatkar, N., Norouzi, N., Patel, D., Nayak, S.S.
    • Year: 2024
    • Citation: Archives of Medical Research, 55(6), 103043
    • Citations: 5
  • Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: An umbrella review
    • Authors: Amini-Salehi, E., Mahapatro, A., Korsapati, R.R., Keivanlou, M.-H., Patel, D.
    • Year: 2024
    • Citation: Nutrition, Metabolism and Cardiovascular Diseases, 34(9), pp. 2046–2054
    • Citations: 4

Yeon-Hee Lee | Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Yeon-Hee Lee | Dentistry | Best Researcher Award

Professor at Kyung Hee University Dental Hospital, South Korea 

Prof. Yeon-Hee Lee is an Associate Professor at Kyung Hee University School of Dentistry, specializing in orofacial pain, temporomandibular disorders (TMD), chronic pain, and the use of artificial intelligence (AI) and machine learning in diagnostics. She holds a PhD from Seoul National University and has gained international experience as a visiting student at Harvard School of Dental Medicine. Her research is impactful, with numerous publications in high-impact journals, focusing on innovative diagnostic methods and pain management. Prof. Lee has contributed significantly to the development of AI-driven tools for diagnosing conditions like xerostomia and TMD. She holds leadership positions in several professional organizations, including the Korean Academy of Temporomandibular Disorders and the Korean Society of Diagnostic Laboratory Dentistry. Her work, which integrates clinical expertise with cutting-edge technologies, positions her as a leader in her field, making substantial contributions to both scientific knowledge and clinical practice in dental medicine.

Professional Profile

Education

Prof. Yeon-Hee Lee has an extensive educational background in dental medicine. She earned her Bachelor’s, Master’s, and Doctoral degrees from Seoul National University, where she also completed her internship and residency in the Department of Oral Medicine and Oral Diagnosis at Seoul National University Dental Hospital. During her studies, she developed a strong foundation in orofacial pain and oral medicine. In addition to her training at Seoul National University, Prof. Lee broadened her academic perspective by spending time as a visiting student at Harvard School of Dental Medicine in 2009. Her advanced studies have been integral to her expertise in temporomandibular disorders, chronic pain, and the application of artificial intelligence in diagnostics. This solid academic background, combined with her clinical training, has played a crucial role in her significant contributions to the fields of dental science, pain management, and medical research.

Professional Experience

Prof. Yeon-Hee Lee has extensive professional experience in the field of orofacial pain and oral medicine. She is currently an Associate Professor in the Department of Orofacial Pain and Oral Medicine at Kyung Hee University School of Dentistry, a position she has held since 2024. Prior to this, she served as an Assistant Professor in the same department from 2020 to 2024 and as a Clinical Assistant Professor at Kyung Hee University Dental Hospital from 2017 to 2020. Prof. Lee began her career at Kyung Hee University as a Fellow in 2015-2017 and gained valuable experience during her internship and residency at Seoul National University Dental Hospital between 2011 and 2015. She has also contributed to advancing the field through leadership roles, including serving as the Executive Director of the Korean Academy of Temporomandibular Disorders and Director of External Cooperation for the Korean Academy of Orofacial Pain and Oral Medicine.

Research Interests

Prof. Yeon-Hee Lee’s research interests are centered on orofacial pain, temporomandibular disorders (TMD), chronic pain, and the application of advanced technologies in diagnosis and treatment. She focuses on understanding the mechanisms of TMD and chronic orofacial pain, which affect a significant portion of the population. Her work explores diagnostic methods, including the use of artificial intelligence (AI) and machine learning to enhance the accuracy and efficiency of identifying conditions like xerostomia, periodontitis, and osteoarthritis. Prof. Lee is particularly interested in integrating AI-driven techniques, such as deep learning, into the clinical setting, to improve diagnostic imaging and predict patient outcomes. Her research also extends to investigating the relationship between oral health and systemic diseases, such as rheumatoid arthritis and osteoarthritis, and identifying new biomarkers for these conditions. By merging clinical expertise with cutting-edge technology, Prof. Lee’s work aims to advance both the scientific understanding and clinical management of orofacial pain and related disorders.

Awards and Honors

Prof. Yeon-Hee Lee has received numerous honors and awards for her contributions to the fields of orofacial pain and oral medicine. She is an active leader in the academic community, serving in several prestigious positions, such as the Executive Director of the Korean Academy of Temporomandibular Disorders and the Director of External Cooperation for the Korean Academy of Orofacial Pain and Oral Medicine. Her leadership also extends to the Korean Society of Diagnostic Laboratory Dentistry, where she serves as an Executive Director. Prof. Lee has been recognized internationally, being a full member of the International Association for Dental Research (IADR) and the Korean Division of IADR. Additionally, she holds a prominent editorial role as the Editor-in-Chief of the Korean Division of IADR and has contributed significantly to advancing the understanding of temporomandibular disorders and pain management. Her ongoing research, leadership, and commitment to her field continue to earn her recognition within both national and international scientific communities.

Conclusion

Yeon-Hee Lee is a highly deserving candidate for the Best Researcher Award. Her extensive contributions to orofacial pain, temporomandibular disorders, and innovative diagnostic techniques are commendable. She exhibits a strong track record of high-quality research, academic leadership, and active participation in professional associations, which makes her a recognized figure in her field. While there are areas for growth, particularly in expanding the scope of her collaborations and outreach, her exceptional research output and leadership make her an ideal contender for this prestigious award.

Publications Top Noted

  • Title: Automatic prediction of obstructive sleep apnea in patients with temporomandibular disorder based on multidata and machine learning
    Author: Lee, Y.-H., Jeon, S., Auh, Q.-S., Chung, E.-J.
    Year: 2024
    Citations: 0
  • Title: Automatic detection and visualization of temporomandibular joint effusion with deep neural network
    Author: Lee, Y.-H., Jeon, S., Won, J.-H., Auh, Q.-S., Noh, Y.-K.
    Year: 2024
    Citations: 0
  • Title: Climate temperature and seasonal influences on the prevalence of temporomandibular disorders in South Korea
    Author: Lee, Y.-H., Chung, J.-W.
    Year: 2024
    Citations: 1
  • Title: Ultrasonographic examination of masticatory muscles in patients with TMJ arthralgia and headache attributed to temporomandibular disorders
    Author: Lee, Y.-H., Bae, H., Chun, Y.-H., Lee, J.-W., Kim, H.-J.
    Year: 2024
    Citations: 0
  • Title: Comparison of ultrasonography-based masticatory muscle thickness between temporomandibular disorders bruxers and temporomandibular disorders non-bruxers
    Author: Lee, Y.-H., Chun, Y.-H., Bae, H., Lee, J.-W., Kim, H.-J.
    Year: 2024
    Citations: 0
  • Title: Investigation of periodontitis, halitosis, xerostomia, and serological characteristics of patients with osteoarthritis and rheumatoid arthritis and identification of new biomarkers
    Author: Lee, Y.-H., Hong, S.-J., Lee, G.-J., Chung, S.W., Lee, Y.-A.
    Year: 2024
    Citations: 1
  • Title: Prediction of xerostomia in elderly based on clinical characteristics and salivary flow rate with machine learning
    Author: Lee, Y.-H., Won, J.H., Auh, Q.-S., Noh, Y.-K., Lee, S.-W.
    Year: 2024
    Citations: 2
  • Title: Orofacial fascial space abscess disguised as temporomandibular disorder: a report of 3 cases and literature review
    Author: Kim, T.-S., Lee, Y.-H.
    Year: 2024
    Citations: 0
  • Title: Association of temporomandibular disorders and reduced masticatory function with dementia in elderly
    Author: Lee, Y.-H.
    Year: 2024
    Citations: 0
  • Title: Ultrasonographic assessment of the lateral pterygoid muscle for BoNT-A injection
    Author: Bae, H., Lee, Y.-H., Kim, S.-B., Hu, K.-S., Kim, H.-J.
    Year: 2024
    Citations: 0